Haleon (HLN) Receivables - Other (2021 - 2025)
Haleon (HLN) posted Receivables - Other of $207.5 million for Q4 2025, down 39.45% on a QoQ basis from $342.7 million in Q4 2024, and down 39.45% year-over-year from $342.7 million in Q4 2024.
Haleon (HLN) Receivables - Other (2021 - 2025) Analysis & Trends
Haleon's Receivables - Other history runs 5 years deep, the most recent figure standing at $207.5 million for Q4 2025.
- Quarterly Receivables - Other fell 39.45% year-over-year to $207.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207.5 million (down 39.45% YoY) and the FY2025 annual result came in at $205.7 million, down 39.73% from the prior year.
- Receivables - Other was $207.5 million for Q4 2025 at Haleon, down from $342.7 million in the prior quarter.
- Across five years, Receivables - Other topped out at $11.6 billion in Q2 2022 and bottomed at $207.5 million in Q4 2025.
- A 5-year average of $2.3 billion and a median of $378.0 million in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other slumped 54.73% — and 2023, when it gained 24.95%.
- Haleon's Receivables - Other stood at $730.6 million in 2021, then slumped by 54.73% to $330.8 million in 2022, then climbed by 24.95% to $413.3 million in 2023, then dropped by 17.08% to $342.7 million in 2024, then slumped by 39.45% to $207.5 million in 2025.
- Business Quant data shows HLN's Receivables - Other at $207.5 million in Q4 2025, $342.7 million in Q4 2024, and $413.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 207.51 Mn |
| Dec 31, 2025 | 207.51 Mn |
| Dec 31, 2024 | 342.69 Mn |
| Dec 31, 2024 | 342.69 Mn |
| Dec 31, 2023 | 413.30 Mn |
| Dec 31, 2023 | 413.30 Mn |
| Dec 31, 2022 | 330.77 Mn |
| Dec 31, 2022 | 330.77 Mn |
| Jun 30, 2022 | 11.60 Bn |
| Jun 30, 2022 | 11.60 Bn |
| Dec 31, 2021 | 730.62 Mn |
| Dec 31, 2021 | 730.62 Mn |